FI911133A0 - Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning. - Google Patents

Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning.

Info

Publication number
FI911133A0
FI911133A0 FI911133A FI911133A FI911133A0 FI 911133 A0 FI911133 A0 FI 911133A0 FI 911133 A FI911133 A FI 911133A FI 911133 A FI911133 A FI 911133A FI 911133 A0 FI911133 A0 FI 911133A0
Authority
FI
Finland
Prior art keywords
terapeutiska
anvaendning
aminomethyl
piperidine
derivatives
Prior art date
Application number
FI911133A
Other languages
English (en)
Other versions
FI911133A (fi
Inventor
Pascal George
Jacques Froissant
Mireille Sevrin
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI911133A0 publication Critical patent/FI911133A0/fi
Publication of FI911133A publication Critical patent/FI911133A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI911133A 1990-03-07 1991-03-06 Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning. FI911133A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9002855A FR2659323B1 (fr) 1990-03-07 1990-03-07 Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
FI911133A0 true FI911133A0 (fi) 1991-03-06
FI911133A FI911133A (fi) 1991-09-08

Family

ID=9394458

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911133A FI911133A (fi) 1990-03-07 1991-03-06 Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning.

Country Status (15)

Country Link
US (1) US5179108A (fi)
EP (1) EP0447292A1 (fi)
JP (1) JPH04217663A (fi)
KR (1) KR910016695A (fi)
AU (1) AU632669B2 (fi)
CA (1) CA2037610A1 (fi)
FI (1) FI911133A (fi)
FR (1) FR2659323B1 (fi)
HU (1) HUT57723A (fi)
IE (1) IE910747A1 (fi)
IL (1) IL97447A0 (fi)
NO (1) NO910874L (fi)
NZ (1) NZ237340A (fi)
PT (1) PT96952A (fi)
ZA (1) ZA911650B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681320B1 (fr) * 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2701479B1 (fr) * 1993-02-11 1995-05-12 Pf Medicament Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
UA58476C2 (uk) * 1997-10-09 2003-08-15 Санофі-Сентелябо Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
FR2769628B1 (fr) * 1997-10-09 1999-11-12 Synthelabo Derives de n-(2,3-dihydro-1h-inden-2-yl)-n-propyl-8- azabicyclo[3.2.1.]octane-3-methanamine, leur preparation et leur application en therapeutique
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
AU2002352124A1 (en) 2001-12-03 2003-06-17 F. Hoffmann-La Roche Ag Aminotetralin derivatives as muscarinic receptor antagonists
ATE492535T1 (de) 2001-12-03 2011-01-15 Hoffmann La Roche 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
WO2004004629A2 (en) * 2002-07-08 2004-01-15 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
US7488748B2 (en) * 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1618091A1 (en) * 2003-04-09 2006-01-25 Ranbaxy Laboratories, Ltd. Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
JP2006522787A (ja) * 2003-04-11 2006-10-05 ランバクシー ラボラトリーズ リミテッド ムスカリン様受容体アンタゴニストとしてのアザビシクロ誘導体
US20100016400A1 (en) * 2004-11-19 2010-01-21 Naresh Kumar Azabicyclic muscarinic receptor antagonists
EP1828126A1 (en) * 2004-12-15 2007-09-05 Ranbaxy Laboratories Limited Acid addition salts of muscarinic receptor antagonists
WO2006117754A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1250719A (fi) * 1969-03-19 1971-10-20
FR2484415A1 (fr) * 1980-06-13 1981-12-18 Pharmindustrie Nouveaux derives de l'indene, procedes pour leur preparation, et leur utilisation comme medicaments
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi

Also Published As

Publication number Publication date
KR910016695A (ko) 1991-11-05
HUT57723A (en) 1991-12-30
ZA911650B (en) 1991-12-24
AU7267091A (en) 1991-09-12
EP0447292A1 (fr) 1991-09-18
FI911133A (fi) 1991-09-08
NO910874D0 (no) 1991-03-06
CA2037610A1 (en) 1991-09-08
NZ237340A (en) 1992-11-25
HU910731D0 (en) 1991-09-30
JPH04217663A (ja) 1992-08-07
US5179108A (en) 1993-01-12
IL97447A0 (en) 1992-06-21
FR2659323B1 (fr) 1992-06-12
FR2659323A1 (fr) 1991-09-13
PT96952A (pt) 1991-10-31
AU632669B2 (en) 1993-01-07
NO910874L (no) 1991-09-09
IE910747A1 (en) 1991-09-11

Similar Documents

Publication Publication Date Title
FI884966A0 (fi) N-substituerade derivat av 1-desoxinojirimycin och desoximannonojirimycin, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI911133A0 (fi) Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning.
FI922647A (fi) Hoegt hyllager att placera och haolla rullformigt gods, speciellt pappersrullar, i lager omfattande parvis anordnade skenor foer lagring av pappersrullarna
NO930306D0 (no) Nye 1,4-dihydropyridinderivater
BR9206272A (pt) Derivados de 2-(4-hidroxipiperidino)-1-alcanol, como agentes anti-isquêmicos.
FI932959A (fi) Kinoxalin derivat, deras framstaellning och anvaendning i laekemedel
NL950021I2 (nl) 2-(Difluormethoxy)-1,1,1,2-tretrafluorethaan als anestheticum.
FI883377A (fi) Derivat av n-aminobutyl-n -fenyl-arylamider, foerfarande foer framstaellning av dessa och terapeutisk anvaendning daerav.
FI891122A (fi) N-cyklopropylaniliner och deras anvaendning i foerfarandet foer framstaellning av 1-cyklopropylkinolonkarboxylsyror och deras derivat.
FI912894A (fi) Foerfarande foer framstaellning av dialkylpyridin-2,3-dikarboxylat och dess derivat ur dialkyldiklorsuccinat.
FI904838A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva karboxitetrahydroisokinoliner och deras derivat.
FI885766A (fi) Nya derivat av cykliska aminosyror, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI904283A0 (fi) Substituerade monoamider av glutarsyra och derivat daerav.
FI861330A0 (fi) 4-(isoxazolyl)-tiazol-2-oxaminsyror och deras derivat.
FI883680A0 (fi) Foerfarande foer behandling av illamaoende med vissa substituerade fenylalkylamino (och aminosyra) derivat.
FI923723A (fi) 4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat
FI873625A0 (fi) Derivat av 2,3-dihydrofuran, deras framstaellningsfoerfarande och anvaendning som mellanprodukt foer framstaellning av tetrahydrofuran.
FI895567A0 (fi) 2-azabicyklo /2,2,1 / hept-5-en-2 -etikssyra, dess derivat och beslaektade foereningar, foerfarande foer framstaellning av naemnda foereningar och anvaendning av naemnda foereningar vid framstaellning av n-fosfonometylglycin.
FI922876A0 (fi) Heterocykliska foereningar med reninhaemmande egenskaper, foerfarande foer framstaellning av dessa och anvaendning av dessa.
FI894758A0 (fi) Derivat av 3-aryloximetyl -cefalosporin, deras framstaellning och medicinska anvaendning.
FI872073A (fi) Derivat av propargyloxybenzener, deras framstaellning och fungicida sammansaettningar i vilka de ingaor.
FI914041A0 (fi) Vattenbaserade herbicida kompositioner av 2-(2-imidazolin-2-yl) pyridiner och -kinoliner.
FI923998A0 (fi) Derivat av maensklig bfgf, deras analoger och foerfarande foer deras framstaellning.
FI901922A0 (fi) Tiazetokinolin-3-karboxylsyraderivat, foerfarande foer deras framstaellning, och en farmaceutisk komposition innehaollande dessa derivat.
FI870896A (fi) Foerfarande foer framstaellning av fosfonyloxiacylaminosyror och deras derivat.